The project application titled "Investigation of the effects of SK-119 and SH-29 pharmacological agents on the Nrf-2 pathway in an in vitro and in vivo atopic dermatitis model" of Prof. Dr. I. Cagatay Karaaslan from Biology Department, Molecular Biology Section and Bioengineering Department, has been accepted within the scope of "Bench to bedside transition for pharmacological regulation of NRF2 in noncommunicable diseases (BenBedPhar)-CA20121" COST action.